
Gilead has signed a deal with San Francisco biotech Nurix Therapeutics – a company focused on developing drugs that control …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

